Barts & The London NHS Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma

Phase 2

Completed

Conditions: Metastatic Seminoma

Interventions: Drug: Carboplatin AUC-10

First Posted Date: 2014-10-23

Last Posted Date: 2019-01-25

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 48

Registration Number: NCT02272816

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom
🇬🇧
Hillingdon Hospitals NHS Foundation Trust, London, United Kingdom

Safety and Efficacy of Paramedic Treatment of Regular Supraventricular Tachycardia

Not Applicable

Conditions: Supraventricular Tachycardia

Interventions: Other: Standard care
Other: Paramedic

First Posted Date: 2014-08-13

Last Posted Date: 2014-08-13

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 90

Registration Number: NCT02216240

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Completed

Conditions: Clostridium Difficile Infection

First Posted Date: 2014-03-13

Last Posted Date: 2024-11-07

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 122

Registration Number: NCT02086916

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)

Not Applicable

Completed

Conditions: Coronary Artery Disease
Diabetes

Interventions: Device: Optical coherence tomography

First Posted Date: 2014-02-12

Last Posted Date: 2015-08-07

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 60

Registration Number: NCT02060357

Locations: 🇬🇧
London Chest Hospital, Barts Health NHS Trust, London, United Kingdom

Achalasia: Mechanisms Underlying Treatment Failure

Terminated

Conditions: Achalasia

First Posted Date: 2014-02-05

Last Posted Date: 2023-09-08

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 40

Registration Number: NCT02055469

Locations: 🇬🇧
Barts Health NHS Trust, London, UK, United Kingdom

A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)

Phase 2

Terminated

Conditions: Castrate Resistant Prostate Cancer

Interventions: Drug: Melphalan
Drug: Lenograstim

First Posted Date: 2013-07-24

Last Posted Date: 2023-04-19

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 29

Registration Number: NCT01907009

Locations: 🇬🇧
St Batholowmew's Hospital NHS, London, United Kingdom

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

Completed

Conditions: Cervical Cancer: Invasive Disease, FIGO Stage 1B1 or Higher
Surgically Staged Endometrial and Cervical Carcinoma
Endometrial Cancer
Stage 1A With Myometrial Invasion or Any Higher Stage and Grade 3
Stage 1A With Myometrial Invasion or Any Other Higher Stage and Serous Papillary or Clear Cell Sub-types
Stage II Disease or Above and Any Histology Grade

Interventions: Diagnostic Test: Diffusion-weighted MRI
Diagnostic Test: Fluorodeoxyglucose-18-PET/CT
Diagnostic Test: Fluoro-ethyl-coline-PET/CT

First Posted Date: 2013-04-22

Last Posted Date: 2020-02-13

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 162

Registration Number: NCT01836484

Locations: 🇬🇧
Queen Elizabeth Hospital, Birmingham University Hospitals, Birmingham NHS Foundation Trust, Birmingham, United Kingdom
🇬🇧
Birmingham City Hospital, Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom
🇬🇧
St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom

and more 4 locations

Paracetamol CSF Pharmacokinetics Study

Phase 4

Completed

Conditions: Paracetamol

Interventions: Drug: Administration of paracetamol

First Posted Date: 2013-04-01

Last Posted Date: 2013-04-04

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 30

Registration Number: NCT01821872

Locations: 🇬🇧
St Bartholomew's Hospital, London, United Kingdom

A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis

Phase 2

Completed

Conditions: Germ Cell Tumour

Interventions: Drug: Combination Chemotherapy

First Posted Date: 2013-02-01

Last Posted Date: 2024-06-14

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 45

Registration Number: NCT01782339

Locations: 🇬🇧
St Bartholomew's Hospital, London, United Kingdom

RFN for SIJ Disease Study

Phase 4

Completed

Conditions: Sacro Iliac Joint Pain

Interventions: Procedure: Comparison of active versus sham radiofrequency neurotomy with Simplicity III

First Posted Date: 2012-11-15

Last Posted Date: 2024-11-05

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 30

Registration Number: NCT01726608

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy